Literature DB >> 7963652

Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment.

P K Young1, F Grinnell.   

Abstract

In this paper, we present a longitudinal study on metalloproteinases in wound-fluid samples collected from three patients with partial- to full-thickness burn wounds. Gelatin zymography showed that 92-kDa gelatinase (MMP-9) and its 225-kDa complex could be detected in burn fluid beginning as early as 4-8 h after injury. Marked increases in MMP-9 levels as well as activation of the proenzyme occurred between day 0 and day 2. The 72-kDa gelatinase (MMP-2) proenzyme was not detected until day 2 and activated enzyme did not appear until day 4. Stromelysin (MMP-3), both proenzyme and activated-enzyme forms, was first observed on day 4. Fluid-phase proteinase activity detected by azocoll degradation roughly corresponded with the level of stromelysin rather than the gelatinases. Our results provide evidence for a regulated metalloproteinase activation cascade following acute traumatic injury and demonstrate in vivo expression of metalloproteinase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963652     DOI: 10.1111/1523-1747.ep12398424

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Impaired wound contraction in stromelysin-1-deficient mice.

Authors:  K M Bullard; L Lund; J S Mudgett; T N Mellin; T K Hunt; B Murphy; J Ronan; Z Werb; M J Banda
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

Review 2.  Fibroblast mechanics in 3D collagen matrices.

Authors:  Sangmyung Rhee; Frederick Grinnell
Journal:  Adv Drug Deliv Rev       Date:  2007-08-14       Impact factor: 15.470

Review 3.  A primer on wound healing in colorectal surgery in the age of bioprosthetic materials.

Authors:  Jonathan B Lundy
Journal:  Clin Colon Rectal Surg       Date:  2014-12

4.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

5.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Design and biofabrication of dermal regeneration scaffolds: role of oligomeric collagen fibril density and architecture.

Authors:  David O Sohutskay; Kevin P Buno; Sunil S Tholpady; Samantha J Nier; Sherry L Voytik-Harbin
Journal:  Regen Med       Date:  2020-03-31       Impact factor: 3.806

7.  Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase.

Authors:  Yuan-Ping Han; Yih-Dar Nien; Warren L Garner
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

8.  Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.

Authors:  Y P Han; T L Tuan; M Hughes; H Wu; W L Garner
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

9.  Matrix metalloproteinase-9 delays wound healing in a murine wound model.

Authors:  Matthew J Reiss; Yan-Ping Han; Edwin Garcia; Mytien Goldberg; Hong Yu; Warren L Garner
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

10.  Binding of matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.